ArticleOncoTargets and therapy2021

EGFR (p. G719A+L747V)/EML4-ALK Co-alterations in Lung Adenocarcinoma with Leptomeningeal Metastasis Responding to Afatinib Treatment: A Case Report.

Zhiqin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.